The American Academy of Ophthalmology (AAO) Minority Ophthalmology Mentoring (MOM) program recently released its 2020 Annual Report. The University of Wisconsin Department of Ophthalmology and Visual Sciences was noted as one of 15 programs that …
Amy Pikalek
Licensed to Lead: Faculty Discuss Physician Burnout and Scribes on Podcast
Barbara Blodi, MD, Matthew D. Davis Professor, medical director of the Fundus Photograph Reading Center and retina specialist, and Mark Lucarelli, MD, FACS, were invited to the Licensed to Lead Podcast for a conversation on …
Low Vision Clinic to Offer Expanded Services
Despite the ongoing challenges presented by the COVID-19 pandemic, the UW Health Low Vision Clinic – led by Sanbrita Mondal, OD, clinical adjunct assistant professor – has announced that it will offer expanded services and …
MAC TEL
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (Mac Tel)
BIM2
To identify whether genetic variation or polymorphism in genes that impact angiogenesis can be identified as biomarkers for responsiveness to anti-VEGF therapy in patients with neovascular age-related macular degeneration.
GENETIC EYE DISORDERS
To identify the gene or genes responsible for developmental causes of blindness in the world, and to establish a Pediatric Ophthalmic Genetics and Research Program at the University of Wisconsin–Madison.
XOLARIS
To gain a better understanding of disease progression over time in male subjects with X-linked retinitis pigmentosa (XLRP).
CHM SURVEY TRIAL
Choroideremia (CHM) Health Outcomes
CATALINA
A Phase II Multicenter, Randomized, Double-Masked, Sham-Controlled Study of the Safety and Efficacy of Intravitreal Injections of NGM621 in Subjects with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (CATALINA)